Menu Search
Equities

Doximity Inc

DOCS:NYQ

Doximity Inc

Actions
Health CareHealth Care Providers
  • Price (USD)40.63
  • Today's Change0.57 / 1.42%
  • Shares traded1.31m
  • 1 Year change+99.17%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Doximity Inc grew revenues 13.45% from 419.05m to 475.42m while net income improved 30.81% from 112.82m to 147.58m.
Gross margin89.65%
Net profit margin32.53%
Operating margin36.51%
Return on assets14.42%
Return on equity16.86%
Return on investment16.39%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Doximity Inc fell by 61.24m. However, the company earned 184.10m from its operations for a Cash Flow Margin of 38.72%. In addition the company generated 31.19m cash from investing, though they paid out 276.52m more in financing than they received.
Cash flow per share0.844
Price/Cash flow per share43.53
Book value per share4.92
Tangible book value per share4.41
More ▼

Balance sheet in USDView more

Doximity Inc uses little or no debt in its capital structure.
Current ratio6.72
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 35.70%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
EPS growth(5 years)192.68
EPS (TTM) vs
TTM 1 year ago		42.35
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.